One hundred sixty-two consecutive patients with strictly defined
vulvar vestibulitis syndrome were asked to fill out a questionnaire with the assistance of their gynecologist. A buccal sample was collected from each subject for the analysis of
interleukin-1 receptor antagonist gene polymorphism; vaginal and vestibular microbial investigations were performed.
RESULTS: Symptoms began with the first act of coitus in 20.4% of patients. A history of a recurrent Candida vulvovaginal
infection was reported in 42.6% of patients; 25.9% of the patients were positive for the homozygous
interleukin-1 receptor antagonist 2,2 genotype. Women with primary
vulvar vestibulitis syndrome differed from women with secondary
vulvar vestibulitis syndrome; women with primary
vulvar vestibulitis syndrome were younger at the time of the onset of the symptoms (23.8 vs 31.2 years, P <.0001) and had never been pregnant (84.8% vs 61.2%, P <.0001). Women with a history of recurrent Candida
vulvovaginitis differed from the other subjects by having a higher frequency of constant vestibular
pain (40.6% vs 20.4%, P =.005), a
vaginal discharge (79.7% vs 45.2%, P <.0001), and
dysuria (62.3% vs 29.0%, P =.0001). Women who were homozygous for
interleukin-1 receptor antagonist 2,2 genotype had an earlier onset of symptoms (26 years) than did women who were allele 1 homozygotes (31.3 years, P <.05). They also had a shorter duration of symptoms (4.1 vs 5.9 years, P <.05) and a higher frequency of
allergy (47.6% vs 23.4%, P =.002). Human papillomavirus in the vaginal vestibule occurred at a greater frequency in women who were homozygous for
interleukin-1 receptor antagonist 2,2 genotype.
CONCLUSION: